We present the results of a single-center trial on early switching from i.v to i.m.anti HBs immunoglobulins (HBG) after liver transplantation.
Early switching to intramuscular anti-HBs Immunoglobulins (Igantibe™) after liver transplantation: feasibility, efficacy, and safety
De Simone, Paolo;Filipponi, Franco
2011-01-01
Abstract
We present the results of a single-center trial on early switching from i.v to i.m.anti HBs immunoglobulins (HBG) after liver transplantation.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
